These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Effect of ultralow doses of antibodies to erythropoietin on antenatal and postnatal development of the offspring.
    Author: Borovskaya TG, Loskutova OP, Abramova EV, Sergeeva SA, Epstein OI, Dygai AM, Goldberg ED.
    Journal: Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():77-9. PubMed ID: 12949658.
    Abstract:
    We studied the effects of ultralow doses of antibodies to erythropoietin on antenatal and postnatal development of rat offspring. Daily administration of the preparation on days 1-6, 6-16, and 16-19 of pregnancy did not increase embryonic mortality and was not associated with congenital malformations, fetal growth retardation, high incidence of pathological changes in fetal organs, and delayed ossification (compared to control and intact animals). For evaluation of their embryotoxic effect manifested in the postnatal period ultralow doses of antibodies to erythropoietin were administered throughout pregnancy. The offspring of treated and intact rats did not differ in physical development, appearance of sensory and locomotor reflexes, locomotor, exploratory, and emotional behavior, and learning and adaptive capacities.
    [Abstract] [Full Text] [Related] [New Search]